Nine Biopharm
Suwon
About Nine Biopharm
Nine Biopharm is biotechnology company that develops new peptidomimetic materials, compound new materials, and drug repositioning.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $6.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: ninebiopharm.com
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/nine-biopharm-184365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.